期刊文献+

幽门螺杆菌、高胃泌素血症对结肠腺瘤形成的作用 被引量:8

Effects of Helicobacter pylori infection and hypergastrinemia on the growth of colonic adenoma
下载PDF
导出
摘要 目的:探讨幽门螺杆菌(H.pylori)感染、血清胃泌素(GAS)与结肠腺瘤的相互关系.方法:采用放射免疫法(RIA)测定结肠腺瘤(n=48)及对照组(n=43)的血清胃泌素水平,用ELISA法检测H.pyloriIgG抗体.给予结肠腺瘤患者口服塞来昔布6mo,分别在2、4、6mo检测血清胃泌素及抗H.pyloriIgG抗体.结果:腺瘤组患者H.pylori感染阳性率、血清胃泌素水平明显高于对照组(P<0.05),结肠腺瘤组血清胃泌素水平与H.pyloriIgG抗体显著相关(r=0.854,P<0.001);远端结肠腺瘤患者H.pylori阳性率显著高于近端结肠(P<0.05),同时高胃泌素血症患者比例明显高于近端结肠(72.7%vs37.8%,P<0.05).口服塞来昔布后,H.pylori阳性率、血清胃泌素水平均趋向下降并且随着服药时间的延长进一步降低.结论:H.pylori感染可诱导高胃泌素血症与结肠腺瘤形成;COX-2可能介导胃泌素诱导的结肠腺瘤形成;口服COX-2抑制剂塞来昔布可以降低H.pylori阳性率及血清胃泌素水平,从而发挥抑制结肠腺瘤生长的作用. AIM:To investigate the association among gastrin level,Helicobacter pylori (H.pylori) infection and the development of colonic adenoma.METHODS:Fasting serum samples from 48 patients with colonic adenomas and 43 demographically matched colonoscopy-negative controls were assayed for anti-H.pylori IgG and serum gastrin levels. Colonic adenoma patients receivedoral celecoxib for 6 months. At the end of the second,fourth and sixth months,serum gastrin levels were measured by radioimmunoassay (RIA) and H.pylori IgG antibody was analyzed by enzyme-linked immunosorbent assay (ELISA). RESULTS:The prevalence of H.pylori seroposi-tivity was significantly higher in patients with colonic adenomas than in controls (68.8% vs 9.30%,P 0.05). Similarly,median gastrin level was signif icantly higher in patients with colonic adenomas than in controls (72.7% vs 37.8%,P 0.05). There was a positive correlation between H.pylori IgG antibody and serum gastrin level in colonic adenoma patients (r = 0.854,P 0.001). Of note,hypergastrinemia was associated with distal colon distribution of adenomas,but not with adenoma number,size,grade or histologi-cal features. After celecoxib treatment,there were parallel falls in serum gastrin levels and H.pylori seropositivity in colonic adenoma patients. CONCLUSION:Hypergastrinemia induced by H.pylori infection is associated with increased cyclooxygenase-2 (COX-2) expression in colonic adenoma,suggesting the possibility that gastrin up-regulates COX-2 expression in colonic ad-enoma. Celecoxib can obviously decrease H.pylori seropositivity and gastrin levels and inhibit the growth of colonic adenomas by down-regulating COX-2 expression.
出处 《世界华人消化杂志》 CAS 北大核心 2010年第13期1390-1394,共5页 World Chinese Journal of Digestology
基金 上海市浦东新区卫生系统重点基金资助项目 No.PWZXK2007-06~~
关键词 结肠腺瘤 幽门螺杆菌 高胃泌素血症 环氧化酶-2 Colonic adenoma Helicobacter pylori Hypergastrinemia Cyclooxygenase-2
  • 相关文献

参考文献15

  • 1Georgopoulos SD,Polymeros D,Triantafyllou K,Spiliadi C,Mentis A,Kaiamanolis DG,Ladas SD.Hypergastrinemia is associated with increased risk of distal colon adenomas.Digestion 2006; 74:42-46.
  • 2Hartwich A,Konturek SJ,Pierzchalski P,Zuchowicz M,Labza H,Konturek PC,Karczewska E,Bielanski W,Marlicz K,Starzynska T,Lawniczak M,Hahn EG.Helicobacter pylori infection,gastrin,cyclooxygenase-2,and apoptosis in colorectal cancer.Int] Colorectal Dis 2001; 16:202-210.
  • 3Masferrer JL,Leahy KM,Koki AT,Zweifel BS,Settle SL,Woerner BM,Edwards DA,Flickinger AG,Moore RJ,Seibert K.Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.Cancer Res 2000; 60:1306-1311.
  • 4Gallo O,Franchi A,Magnelli L,Sardi I,Vannacci A,Boddi V,Chiarugi V,Masini E.Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer.Implications for tumor angiogenesis and metastasis.Neoplasia 2001; 3:53-61.
  • 5Jones M,Helliwell P,Pritchard C,Tharakan J,Mathew J.Helicobacter pylori in colorectal neoplasms:is there an aetiological relationship? World J Surg Oncol 2007; 5:51.
  • 6Soylu A,OzkaraS,Alis H,Dolay K,KalayciM,Yasar N,Kumbasar AB.Immunohistochemical testing for Helicobacter Pylori existence in neoplasms of the coloa BMC Gastroenterol 2008; 8:35.
  • 7Oset P,Jasinska A,Szczesniak P,Orszulak-Michalak D,Talar-Wojnarowska R,Malecka-Panas E.[Analysis of serum gastrin levels in patients with adenomatous polyps of the colon] Pol Merkur Lekarski 2009; 26:458-461.
  • 8Smith AM,Watson SA.Gastrin and gastrin receptor activation:an early event in the adenoma-carcinoma sequence.Gut 2000; 47:820-824.
  • 9Mizuno S,Morita Y,Inui T,Asakawa A,Ueno N,Ando T,Kato H,Uchida M,Yoshikawa T,Inui A.Helicobacter pylori infection is associated with colon adenomatous polyps detected by high-resolution colonoscopy.Int] Cancer 2005; 117:1058-1059.
  • 10罗伟仁,陈小毅.环氧化酶-2与肿瘤的关系[J].肿瘤防治研究,2006,33(1):62-64. 被引量:18

二级参考文献33

  • 1汪洋,林从尧,周夏.大肠癌中β-catenin表达及与COX-2、VEGF表达的关系[J].肿瘤防治研究,2006,33(1):20-22. 被引量:19
  • 2罗伟仁,陈小毅.环氧化酶-2与肿瘤的关系[J].肿瘤防治研究,2006,33(1):62-64. 被引量:18
  • 3Deeks J J, Smith LA, bradeley MD, et al. Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and theumatoid arthritis : systematic review of randomized controlled trials[J]. BMJ, 2002 , 325 (7365) :607-608.
  • 4Steinbach G, Lynch PM,Phillips RK, et al. The effect of celecoxib , a cyclooxygenase-2 inhibitor , in familial adenomatous polyposis[J] . N Engl J Med ,2000 ,342 (26):1946-1952.
  • 5Smakman N, Kranenburg O, Vogten JM,et al. Cyclooxygenase-2 Is a Target of KRASD12, WhichFacilitates the Outgrowth of Murine C26 Colorectal Liver Metastases[J]. Clin Cancer Res, 2005,11 ( 1 ) : 41-48.
  • 6Lim JW, Kim H , Kim KH. Nuclear factor-kappaB regulates cyclooxygenase-2 expressioned cell proliferation in human gastric cell[J]. LabInvest,2001,81 (3) :349-360.
  • 7A kh tarM, Cheng Y, M agno RM , et al. Promoter methylationregulates helicobacter pylori-stimulated cyclooxygenase-2 expression in gastric epthelial cells[J]. Cancer Res, 2001,61(6):2399-2403.
  • 8Oshima M ,Murai N ,Kargman S, et al. Chemop revention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor[J]. Cancer Res, 2001,61(4):1733-1740.
  • 9Zhang H ,Sun XF. Overexpression of cyclooxygenase-2 correlares with advanced stages of colorectal cancer[J]. Am J Gastroenterol ,2002 ,97(4):1037-1041.
  • 10Uefuji K, Ich ikura T, Moch izuk i H. Expression of cyclooxygenase-2 in human gastric adenomas and adenocarcinomas[J]. J Surg Oncol,2001,76(1):26-30.

共引文献36

同被引文献88

引证文献8

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部